Senderra Specialty Pharmacy has announced placements providing access for five Humira (adalimumab) biosimilars across its network and pledged to announce new partnerships and product availability as other biosimilars reach the US marketplace.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Generics Bulletin for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?